Results 181 to 190 of about 3,423 (190)

RIPK3‐mediated cell death is involved in DUX4‐mediated toxicity in facioscapulohumeral dystrophy

Journal of Cachexia, Sarcopenia and Muscle, 2021
Virginie Mariot, Romain Joubert, Laura Le Gall   +2 more
exaly  

Influence of DUX4 Expression in Facioscapulohumeral Muscular Dystrophy and Possible Treatments

International Journal of Molecular Sciences, 2023
Elisa Duranti, Chiara Villa, Villa Chiara   +2 more
exaly  

DUX4 Transcript Knockdown with Antisense 2′-O-Methoxyethyl Gapmers for the Treatment of Facioscapulohumeral Muscular Dystrophy

Molecular Therapy, 2021
Kenji Rowel Q Lim, Rika Maruyama, Yusuke Echigoya   +2 more
exaly  

The DUX4 protein is a co‐repressor of the progesterone and glucocorticoid nuclear receptors

FEBS Letters, 2022
Nizar Y Saad, Scott Q Harper, Alberto Luis Rosa   +2 more
exaly  

The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein

Neuromuscular Disorders, 2007
Eugenie Ansseau, Cecilia Conde, Oberdan Leo   +2 more
exaly  

DUX4 Suppresses MHC Class I to Promote Cancer Immune Evasion and Resistance to Checkpoint Blockade

Developmental Cell, 2019
Guo-Liang Chew, Amy E Campbell, Sean C Shadle   +2 more
exaly  

Dux4 induces cell cycle arrest at G1 phase through upregulation of p21 expression

Biochemical and Biophysical Research Communications, 2014
Zhaoxia Wang, Hongjun Hao, Lemin Zheng   +2 more
exaly  

NFE2L3 Controls Colon Cancer Cell Growth through Regulation of DUX4, a CDK1 Inhibitor

Cell Reports, 2019
Benjamin Le Calve, Frédéric Lessard, Thomas Dal Maso   +2 more
exaly  

CIC-DUX4 sarcoma

openaire   +1 more source

Nuclear DUX4 immunohistochemistry is a highly sensitive and specific marker for the presence of CIC::DUX4 fusion in CIC‐rearranged sarcomas: a study of 48 molecularly confirmed cases

Histopathology
Rodrigo T Macedo, Tamás Pancsa, Natalie Klubíčková   +2 more
exaly